The Editor-in-Chief, Eric Rowinsky, and Associate Editors, Alex A. Adjei, S. Gail Eckhardt, Manuel Hidalgo, Hagop Kantarjian, Razelle Kurzrock, Eric Raymond, Lillian Siu, Alex Sparreboom, Josep Tabernero, Jaap Verweij and Springer would like to acknowledge and thank the reviewers for their essential contribution to the journal.
Udai Banerji
Rolf Barth
Tanios Bekaii-Saab
Bob Benjamin
Shimon Ben-Shabat
Christopher Bradley
Jason Bush
Emiliano Calvo
Dharminder Chauhan
Li-Tzong Chen
Minsig Choi
Quincy Chu
Joseph Ciccolini
Nicola Curtin
Piotr Czaykowski
Naval Daver
Olivier de Wever
Courtney DiNardo
Maurizio D'Incalci
Alan Eastman
Martin Edelman
Richard J. Epstein
Charles Erlichman
Robert Fürst
Junji Furuse
Ignacio Garrido-Laguna
Hans Gelderblom
David M. Gershenson
Julia Glade-Bender
Marie Gran
Jhanelle Gray
Petros Grivas
Guohong Han
R. Donald Harvey
Daniel Hoth
Shile Huang
Clara Hwang
Akira Inoue
Stephen Isakoff
Hiroyasu Kaneda
Anand Karnad
Peter Kristensen
Yogesh Kulkarni
Scott Laurie
Christophe Le tourneau
Anait Levenson
Sam Lubner
Harry Lybeck
Christophe Massard
Inaam Nakchbandi
Bart Neyns
W.T. Ng
Naoyuki Nogami
Philip Oldfield
Shubham Pant
Agostino Ponzetti
Federico Quaini
Michel Roberge
Yuh Sakata
Carmen Sanmartin
Edward Schwartz
Sidney Scuder
Thomas Semrad
Gautam Sethi
Andrean Simons-Burnett
Patricia J Simpson-Haidaris
Tripti Singh
Lillian Siu
Nikolajs Sjakste
Robert Somer
A. Sparreboom
Hiroyoshi Suzuki
Karthik Venkatakrishnan
Michael Vickers
Emile Voest
Sebastian Cosmin Voican
Colin Weekes
R. Zauhar
Chen Zhao
Vassilis Zoumpourlis
Rights and permissions
About this article
Cite this article
Acknowledgement of Reviewers 2015. Invest New Drugs 34, 138 (2016). https://doi.org/10.1007/s10637-015-0312-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-015-0312-9